Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity

Reporting to the Executive Director, Global Disease Area Insights, the Senior Director, Global Disease Area Insights role requires strategic thinking and expertise to provide broad-level critical contributions to disease area strategy, life-cycle planning and product and portfolio decisions. The individual in this role will lead the global team responsible for integrated market research and competitive intelligence to support the development and commercialization of the RevMed portfolio for a given disease area. The role will identify unmet needs and market gaps, assess the significance of emerging developments, and evaluate proposed commercial strategies and solutions to inform decisions and improve market impact. The ideal candidate will have experience working on pipeline and commercial-stage molecules in Oncology across multiple geographies, a strong ability to advise and influence senior leadership, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and comfort with ambiguity.

This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.

Responsibilities include:

Leads Market Research and Competitive Strategy team members to develop an integrated, continuously updated view of the external environment for a given disease area, inclusive of competitor pipelines, emerging science, clinical data, commercial activities, market developments, and stakeholder insights in support of current business needs and future opportunities across the portfolio of targeted oncology molecules.

Initiates and facilitates market research to deepen understanding of market opportunity, unmet needs, stakeholder behaviors, and gaps or barriers in the marketplace. Pressure-tests assumptions about the nature and importance of these gaps and evaluates proposed commercial strategies, solutions, and approaches for their potential to influence behavior and improve market outcomes.

Leads systematic, ongoing tracking and synthesis of competitive information across medical conferences, earnings calls and investor events, scientific publications, clinical and regulatory updates, and commercial activities, positioning, and messaging. Coordinates congress coverage and deliver timely alerts, integrated summaries, and implications tailored to stakeholder needs.

Benchmarks competitor clinical data, messaging, positioning, commercial strategies and execution, business models, and capabilities. Anticipates potential competitive moves and assesses their implications for differentiation, disease area strategy, and commercial planning.

Collaborates with key stakeholders to identify and prioritize intelligence and research needs, translate business questions into learning objectives, and generate insights through appropriate research, competitive intelligence, and analytical approaches.

Communicates and aligns key internal stakeholders around market research and competitive intelligence objectives and outputs, distinguishing established evidence from assumptions and qualifying findings based on data quality, uncertainty, and limitations.